Imdelltra Disease Interactions
There are 2 disease interactions with Imdelltra (tarlatamab).
Moderate
Tarlatamab (applies to Imdelltra) hepatic dysfunction
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease
The effects of moderate to severe hepatic impairment on the pharmacokinetics of tarlatamab are unknown.
Moderate
Tarlatamab (applies to Imdelltra) renal dysfunction
Moderate Potential Hazard, Moderate plausibility.
The effects of severe renal impairment (eGFR 15 to 29 mL/min) and end-stage renal disease (eGFR less than 15 mL/min) on the pharmacokinetics of tarlatamab are unknown.
Switch to professional interaction data
Imdelltra drug interactions
There are 363 drug interactions with Imdelltra (tarlatamab).
Report options
QR code containing a link to this page
More about Imdelltra (tarlatamab)
- Imdelltra consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: bispecific T-cell engagers (BiTE)
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
